Anaphylatoxins spark the flame in early autoimmunity

The complement system (CS) is an ancient and highly conserved part of the innate immune system with important functions in immune defense. The multiple fragments bind to specific receptors on innate and adaptive immune cells, the activation of which translates the initial humoral innate immune respo...

Full description

Bibliographic Details
Main Authors: Jovan Schanzenbacher, Jörg Köhl, Christian M. Karsten
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.958392/full
_version_ 1828397791813042176
author Jovan Schanzenbacher
Jörg Köhl
Jörg Köhl
Christian M. Karsten
author_facet Jovan Schanzenbacher
Jörg Köhl
Jörg Köhl
Christian M. Karsten
author_sort Jovan Schanzenbacher
collection DOAJ
description The complement system (CS) is an ancient and highly conserved part of the innate immune system with important functions in immune defense. The multiple fragments bind to specific receptors on innate and adaptive immune cells, the activation of which translates the initial humoral innate immune response (IR) into cellular innate and adaptive immunity. Dysregulation of the CS has been associated with the development of several autoimmune disorders such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), ANCA-associated vasculitis, and autoimmune bullous dermatoses (AIBDs), where complement drives the inflammatory response in the effector phase. The role of the CS in autoimmunity is complex. On the one hand, complement deficiencies were identified as risk factors to develop autoimmune disorders. On the other hand, activation of complement can drive autoimmune responses. The anaphylatoxins C3a and C5a are potent mediators and regulators of inflammation during the effector phase of autoimmunity through engagement of specific anaphylatoxin receptors, i.e., C3aR, C5aR1, and C5aR2 either on or in immune cells. In addition to their role in innate IRs, anaphylatoxins regulate humoral and cellular adaptive IRs including B-cell and T-cell activation, differentiation, and survival. They regulate B- and T-lymphocyte responses either directly or indirectly through the activation of anaphylatoxin receptors via dendritic cells that modulate lymphocyte function. Here, we will briefly review our current understanding of the complex roles of anaphylatoxins in the regulation of immunologic tolerance and the early events driving autoimmunity and the implications of such regulation for therapeutic approaches that target the CS.
first_indexed 2024-12-10T08:52:51Z
format Article
id doaj.art-5a5e55fcddfc433b83eb4e267c8364d7
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-10T08:52:51Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-5a5e55fcddfc433b83eb4e267c8364d72022-12-22T01:55:32ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-07-011310.3389/fimmu.2022.958392958392Anaphylatoxins spark the flame in early autoimmunityJovan Schanzenbacher0Jörg Köhl1Jörg Köhl2Christian M. Karsten3Institute for Systemic Inflammation Research, University of Lübeck, Lübeck, GermanyInstitute for Systemic Inflammation Research, University of Lübeck, Lübeck, GermanyDivision of Immunobiology, Cincinnati Childrens Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, United StatesInstitute for Systemic Inflammation Research, University of Lübeck, Lübeck, GermanyThe complement system (CS) is an ancient and highly conserved part of the innate immune system with important functions in immune defense. The multiple fragments bind to specific receptors on innate and adaptive immune cells, the activation of which translates the initial humoral innate immune response (IR) into cellular innate and adaptive immunity. Dysregulation of the CS has been associated with the development of several autoimmune disorders such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), ANCA-associated vasculitis, and autoimmune bullous dermatoses (AIBDs), where complement drives the inflammatory response in the effector phase. The role of the CS in autoimmunity is complex. On the one hand, complement deficiencies were identified as risk factors to develop autoimmune disorders. On the other hand, activation of complement can drive autoimmune responses. The anaphylatoxins C3a and C5a are potent mediators and regulators of inflammation during the effector phase of autoimmunity through engagement of specific anaphylatoxin receptors, i.e., C3aR, C5aR1, and C5aR2 either on or in immune cells. In addition to their role in innate IRs, anaphylatoxins regulate humoral and cellular adaptive IRs including B-cell and T-cell activation, differentiation, and survival. They regulate B- and T-lymphocyte responses either directly or indirectly through the activation of anaphylatoxin receptors via dendritic cells that modulate lymphocyte function. Here, we will briefly review our current understanding of the complex roles of anaphylatoxins in the regulation of immunologic tolerance and the early events driving autoimmunity and the implications of such regulation for therapeutic approaches that target the CS.https://www.frontiersin.org/articles/10.3389/fimmu.2022.958392/fullcomplementanaphylatoxinsC3aC5aearly autoimmunitybreak of tolerance
spellingShingle Jovan Schanzenbacher
Jörg Köhl
Jörg Köhl
Christian M. Karsten
Anaphylatoxins spark the flame in early autoimmunity
Frontiers in Immunology
complement
anaphylatoxins
C3a
C5a
early autoimmunity
break of tolerance
title Anaphylatoxins spark the flame in early autoimmunity
title_full Anaphylatoxins spark the flame in early autoimmunity
title_fullStr Anaphylatoxins spark the flame in early autoimmunity
title_full_unstemmed Anaphylatoxins spark the flame in early autoimmunity
title_short Anaphylatoxins spark the flame in early autoimmunity
title_sort anaphylatoxins spark the flame in early autoimmunity
topic complement
anaphylatoxins
C3a
C5a
early autoimmunity
break of tolerance
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.958392/full
work_keys_str_mv AT jovanschanzenbacher anaphylatoxinssparktheflameinearlyautoimmunity
AT jorgkohl anaphylatoxinssparktheflameinearlyautoimmunity
AT jorgkohl anaphylatoxinssparktheflameinearlyautoimmunity
AT christianmkarsten anaphylatoxinssparktheflameinearlyautoimmunity